Flagship Harbor Advisors’s Immunomedics Inc IMMU Stock Holding History

Flagship Harbor Advisors’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-200	Closed	-$17K	–	2004
2020 Q3	$17K	Hold	200	–	–	﹤0.01%	1197
2020 Q2	$7K	Hold	200	–	–	﹤0.01%	1496
2020 Q1	$3K	Hold	200	–	–	﹤0.01%	1601
2019 Q4	$4K	Sell	200 -908	-82%	-$16K	﹤0.01%	1614
2019 Q3	$14K	Sell	1,108 -175	-14%	-$2.57K	﹤0.01%	1213
2019 Q2	$17K	Sell	1,283 -155	-11%	-$2.33K	﹤0.01%	1148
2019 Q1	$27K	Sell	1,438 -155	-10%	-$2.5K	0.01%	961
2018 Q4	$22K	Hold	1,593	–	–	0.01%	988
2018 Q3	$32K	Hold	1,593	–	–	0.01%	961
2018 Q2	$37K	Buy	+1,593	New	+$32K	0.01%	904

Flagship Harbor Advisors's IMMU Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 200 shares — an estimated $17K sold.

Flagship Harbor Advisors first reported a position in IMMU in Q2 2018 and held it in 10 quarters. The position peaked at $37K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

Flagship Harbor Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
Flagship Harbor Advisors sold 200 Immunomedics Inc shares in Q4 2020, an estimated $17K.
Flagship Harbor Advisors first reported a position in Immunomedics Inc in Q2 2018 and held it in 10 quarters.
Flagship Harbor Advisors's Immunomedics Inc position peaked at $37K in Q2 2018.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.